专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2018039559A2 MATERIALS HANDLING VEHICLE OBSTACLE SCANNING TOOLS 审中-公开
标题翻译：材料处理车辆障碍物扫描工具
公开(公告)号：WO2018039559A2
公开(公告)日：2018-03-01
申请号：PCT/US2017/048612
申请日：2017-08-25
申请人： CROWN EQUIPMENT CORPORATION , MAI, Yuan , STEWART, Alan
发明人： MAI, Yuan , STEWART, Alan
IPC分类号： G05D1/02 , B66F9/06
摘要： A materials handling vehicle comprises an obstacle scanning tool and steering mechanism, materials handling hardware, vehicle drive mechanism, and user interface that facilitate movement of the materials handling vehicle and materials handled along a travel path. The tool establishes a scan field, a filter field, and a performance field, and is configured to indicate the presence of obstacles in the filter field and the performance field. The tool executes logic to establish the performance field in response to an input performance level, scan for obstacles in the filter field and the performance field, execute obstacle avoidance for obstacles detected in the filter field, and execute a performance level reduction inquiry for obstacles detected in the performance field wherein outcomes of the inquiry comprise reduction of the performance level when a performance level reduction is available and execution of obstacle avoidance when a performance level reduction is not available.
摘要翻译：物料搬运车辆包括障碍扫描工具和转向机构，物料搬运硬件，车辆驱动机构以及便于物料搬运车辆和沿着行进路径处理的物料的移动的用户界面。该工具建立一个扫描区域，一个过滤区域和一个性能区域，并被配置为指示过滤区域和性能区域中存在障碍物。该工具执行逻辑以响应于输入性能水平来建立性能字段，扫描过滤器字段和性能字段中的障碍物，对在过滤器字段中检测到的障碍物执行障碍物避免，并对检测到的障碍物执行性能水平降低查询在性能领域中，询问的结果包括在性能水平降低可用时降低性能水平，以及当性能水平降低不可用时执行障碍避免。

2. 发明申请

WO2006026753A3 DISTRIBUTED NETWORKING AGENT (DNA) AND METHODS OF MAKING AND USING THE SAME 审中-公开
标题翻译：分布式网络代理（DNA）及其制造和使用方法
公开(公告)号：WO2006026753A3
公开(公告)日：2006-07-20
申请号：PCT/US2005031296
申请日：2005-09-02
申请人： GEN DYNAMICS C4 SYSTEMS INC , CARRILLO STEVE , BRISTOW PAUL , STEWART ALAN , STEWART RICHARD , KELLEY WILLIAM
发明人： CARRILLO STEVE , BRISTOW PAUL , STEWART ALAN , STEWART RICHARD , KELLEY WILLIAM
IPC分类号： G06F15/16 , H04W16/00 , H04W16/18 , H04W24/00 , H04W28/06 , H04W28/16 , H04W40/18 , H04W40/38 , H04W72/12 , H04W76/02
CPC分类号： H04W16/18 , H04L41/042 , H04L41/046 , H04L41/083 , H04L41/12 , H04L41/145 , H04L41/5003 , H04L41/5009 , H04L43/0829 , H04L43/0852 , H04L43/16 , H04W24/02 , H04W24/04 , H04W28/16 , H04W40/18 , H04W40/38
摘要： The present invention relates to an agent for distributed networking(170) and a processor-readable software code. The agent may include, for example, a cosite analyzer (178), an EMI sniffer (177), an asset controller module (179), an asset discovery module, and a link negotiator (181). The agent may be configured to initiate and optimize network configurations for radio communications systems based on parameters. The software code may receive data associated with a network plan, may determine if any planned links (448) are included in the network plan and may establish connectivity of a confirmed link between at least two nodes (105, 110) in the network (100). Additionally, the software code may determine (171) if a non-planned link should be added to the network and may establish connectivity for the non-planned link based on a priority associated with the non-planned link.
摘要翻译：本发明涉及用于分布式组网（170）和处理器可读软件代码的代理。代理可以包括例如电话分析器（178），EMI嗅探器（177），资产控制器模块（179），资产发现模块和链接协商器（181）。代理可以被配置为基于参数来发起和优化用于无线电通信系统的网络配置。软件代码可以接收与网络规划相关联的数据，可以确定网络规划中是否包括任何计划的链路（448），并且可以建立网络中的至少两个节点（105,110）之间的已确认链路的连通性（100））。另外，软件代码可以确定（171）是否应该将非计划链路添加到网络中，并且可以基于与非规划链路相关联的优先级为非规划链路建立连接。

3. 发明申请

WO2006026753A2 DISTRIBUTED NETWORKING AGENT (DNA) AND METHODS OF MAKING AND USING THE SAME 审中-公开
标题翻译：分布式联网代理（DNA）及其制作和使用方法
公开(公告)号：WO2006026753A2
公开(公告)日：2006-03-09
申请号：PCT/US2005/031296
申请日：2005-09-02
申请人： GENERAL DYNAMICS C4 SYSTEMS, INC. , CARRILLO, Steve , BRISTOW, Paul , STEWART, Alan , STEWART, Richard , KELLEY, William
发明人： CARRILLO, Steve , BRISTOW, Paul , STEWART, Alan , STEWART, Richard , KELLEY, William
IPC分类号： H04Q7/00
CPC分类号： H04W16/18 , H04L41/042 , H04L41/046 , H04L41/083 , H04L41/12 , H04L41/145 , H04L41/5003 , H04L41/5009 , H04L43/0829 , H04L43/0852 , H04L43/16 , H04W24/02 , H04W24/04 , H04W28/16 , H04W40/18 , H04W40/38
摘要： The present invention relates to an agent for distributed networking and a processor-readable software code. The agent may include, for example, a cosite analyzer, an EMI sniffer, an asset controller module, an asset discovery module, and a link negotiator. The agent may be configured to initiate and optimize network configurations for radio communications systems based on parameters. The software code may receive data associated with a network plan, may determine if any planned links are included in the network plan and may establish connectivity of a confirmed link between at least two nodes in the network. Additionally, the software code may determine if a non-planned link should be added to the network and may establish connectivity for the non-planned link based on a priority associated with the non-planned link.
摘要翻译：本发明涉及用于分布式联网的代理和处理器可读的软件代码。该代理可以包括，例如，约瑟夫分析器，EMI嗅探器，资产控制器模块，资产发现模块和链路协商器。代理可以被配置为基于参数发起和优化无线电通信系统的网络配置。软件代码可以接收与网络计划相关联的数据，可以确定网络计划中是否包括任何计划的链接，并且可以建立网络中的至少两个节点之间的确认的链接的连接。另外，软件代码可以确定是否应该将非计划链接添加到网络，并且可以基于与非计划链接相关联的优先级为非计划链接建立连接性。

4. 发明申请

WO0220609A2 NEW USE 审中-公开
标题翻译：新用途
公开(公告)号：WO0220609A2
公开(公告)日：2002-03-14
申请号：PCT/EP0109923
申请日：2001-08-27
申请人： SMITHKLINE BEECHAM PLC , BATES STEWART ALAN , GLOGER ISRAEL SIMON , READ SIMON
发明人： BATES STEWART ALAN , GLOGER ISRAEL SIMON , READ SIMON
IPC分类号： A61K38/00 , A61P9/10 , A61P25/02 , C07K14/54
CPC分类号： C07K14/5431 , A61K38/00
摘要： New uses for interleukin 11 polypeptides and polynucleotides encoding IL-11 polypeptides are disclosed. Such uses include their use in therapy and in identifying agonist compounds which are potentially useful in therapy.
摘要翻译：公开了白介素11多肽和编码IL-11多肽的多核苷酸的新用途。这些用途包括它们在治疗中的用途以及鉴定潜在可用于治疗的激动剂化合物。

5. 发明申请

WO2011147951A8 CYCLOAMINO DERIVATIVES AS GPR119 AGONISTS 审中-公开
标题翻译： CYCLOAMINO衍生物作为GPR119激动剂
公开(公告)号：WO2011147951A8
公开(公告)日：2012-03-15
申请号：PCT/EP2011058703
申请日：2011-05-27
申请人： PROSIDION LTD , BARBA OSCAR , BELL JAMES CHARLES , DUPREE TOM BANKSIA , FRY PETER TIMOTHY , BERTRAM LISA SARAH , FYFE MATTHEW COLIN THOR , GATTRELL WILLIAM , JEEVARATNAM REVATHY PERPETUA , KEILY JOHN , KRULLE THOMAS MARTIN , MCDONALD RUSSELL WALKER , MORGAN TREVOR , RASAMISON CHRYSTELLE MARIE , SCHOFIELD KAREN LESLEY , STEWART ALAN JOHN WILLIAM , SWAIN SIMON ANDREW , WITHALL DAVID MATTHEW
发明人： BARBA OSCAR , BELL JAMES CHARLES , DUPREE TOM BANKSIA , FRY PETER TIMOTHY , BERTRAM LISA SARAH , FYFE MATTHEW COLIN THOR , GATTRELL WILLIAM , JEEVARATNAM REVATHY PERPETUA , KEILY JOHN , KRULLE THOMAS MARTIN , MCDONALD RUSSELL WALKER , MORGAN TREVOR , RASAMISON CHRYSTELLE MARIE , SCHOFIELD KAREN LESLEY , STEWART ALAN JOHN WILLIAM , SWAIN SIMON ANDREW , WITHALL DAVID MATTHEW
IPC分类号： C07D401/14 , A61K31/454 , A61P3/10 , C07D409/14 , C07D413/14 , C07D417/14 , C07D487/04 , C07D491/08
CPC分类号： C07D413/14 , C07D401/14 , C07D409/14 , C07D417/14 , C07D487/04 , C07D491/08
摘要： Therapeutic compounds are disclosed having the general formula (I) that are useful for the treatment of metabolic disorders, including type II diabetes. The compounds have activity as agonists of GPR119. Compounds having the stereochemistry of formula (la) may also demonstrate DPP-IV inhibitory activity.
摘要翻译：公开了具有通式（I）的治疗化合物，其可用于治疗代谢紊乱，包括II型糖尿病。这些化合物作为GPR119的激动剂具有活性。具有式（Ia）立体化学的化合物也可以表现出DPP-IV抑制活性。

6. 发明申请

WO2011147951A1 CYCLOAMINO DERIVATIVES AS GPR119 ANTAGONISTS 审中-公开
标题翻译： CYCLOAMINO衍生物作为GPR119拮抗剂
公开(公告)号：WO2011147951A1
公开(公告)日：2011-12-01
申请号：PCT/EP2011/058703
申请日：2011-05-27
申请人： PROSIDION LIMITED , BARBA, Oscar , BELL, James, Charles , DUPREE, Tom, Banksia , FRY, Peter, Timothy , BERTRAM, Lisa, Sarah , FYFE, Matthew, Colin, Thor , GATTRELL, William , JEEVARATNAM, Revathy, Perpetua , KEILY, John , KRULLE, Thomas, Martin , MCDONALD, Russell, Walker , MORGAN, Trevor , RASAMISON, Chrystelle, Marie , SCHOFIELD, Karen, Lesley , STEWART, Alan, John, William , SWAIN, Simon, Andrew , WITHALL, David, Matthew
发明人： BARBA, Oscar , BELL, James, Charles , DUPREE, Tom, Banksia , FRY, Peter, Timothy , BERTRAM, Lisa, Sarah , FYFE, Matthew, Colin, Thor , GATTRELL, William , JEEVARATNAM, Revathy, Perpetua , KEILY, John , KRULLE, Thomas, Martin , MCDONALD, Russell, Walker , MORGAN, Trevor , RASAMISON, Chrystelle, Marie , SCHOFIELD, Karen, Lesley , STEWART, Alan, John, William , SWAIN, Simon, Andrew , WITHALL, David, Matthew
IPC分类号： C07D401/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D487/04 , C07D491/08 , A61K31/454 , A61P3/10
CPC分类号： C07D413/14 , C07D401/14 , C07D409/14 , C07D417/14 , C07D487/04 , C07D491/08
摘要： Therapeutic compounds are disclosed having the general formula (I) that are useful for the treatment of metabolic disorders, including type II diabetes. The compounds have activity as agonists of GPR119. Compounds having the stereochemistry of formula (la) may also demonstrate DPP-IV inhibitory activity.
摘要翻译：公开了具有通式（I）的治疗化合物，其可用于治疗代谢紊乱，包括II型糖尿病。这些化合物作为GPR119的激动剂具有活性。具有式（Ia）立体化学的化合物也可以表现出DPP-IV抑制活性。

7. 发明申请

WO2011128395A1 N- SUBSTITUTED 3-AMINO 4 - ( PYRROLIDINE - 1 - CARBONYL) PYRROLIDINE AND ITS DERIVATIVES FOR USE IN THE TREATMENT OF METABOLIC DISORDERS 审中-公开
标题翻译： N-取代的3-氨基-4-（吡咯烷-1-羰基）吡咯烷及其用于治疗代谢性疾病的衍生物
公开(公告)号：WO2011128395A1
公开(公告)日：2011-10-20
申请号：PCT/EP2011/055865
申请日：2011-04-13
申请人： PROSIDION LIMITED , BARBA, Oscar , DUPREE, Tom , SCHOFIELD, Karen , STEWART, Alan , SWAIN, Simon , WITHALL, David
发明人： BARBA, Oscar , DUPREE, Tom , SCHOFIELD, Karen , STEWART, Alan , SWAIN, Simon , WITHALL, David
IPC分类号： A61K31/454 , A61K31/4545 , A61K31/506 , A61P3/10
CPC分类号： A61K31/454 , A61K31/4545 , A61K31/506 , C07D401/12 , C07D401/14 , C07D413/14
摘要： The present invention is directed to therapeutic compounds which have activity as agonists of GPR119 and are useful for the treatment of metabolic disorders including type II diabetes. The compounds may also inhibit DPP-IV enzyme activity.
摘要翻译：本发明涉及具有作为GPR119激动剂的活性并且可用于治疗包括II型糖尿病的代谢性疾病的治疗性化合物。这些化合物还可以抑制DPP-IV酶的活性。

8. 发明申请

WO2008142454A1 BICYCLIC ARYL AND HETEROARYL COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS 审中-公开
标题翻译：用于治疗代谢性疾病的双相ARYL和HETEROARYL化合物
公开(公告)号：WO2008142454A1
公开(公告)日：2008-11-27
申请号：PCT/GB2008/050370
申请日：2008-05-22
申请人： PROSIDION LIMITED , BLOXHAM, Jason , BRADLEY, Stuart, Edward , DUPREE, Tom, Banksia , FRY, Peter, Timothy , HANRAHAN, Patrick, Eric , KRULLE, Thomas, Martin , PROCTER, Martin, James , SAMBROOK-SMITH, Colin, Peter , SCHOFIELD, Karen, Lesley , SMYTH, Donald , STEWART, Alan, John, William
发明人： BLOXHAM, Jason , BRADLEY, Stuart, Edward , DUPREE, Tom, Banksia , FRY, Peter, Timothy , HANRAHAN, Patrick, Eric , KRULLE, Thomas, Martin , PROCTER, Martin, James , SAMBROOK-SMITH, Colin, Peter , SCHOFIELD, Karen, Lesley , SMYTH, Donald , STEWART, Alan, John, William
IPC分类号： C07D213/62 , C07D401/12 , C07D405/12 , C07D409/12 , A61K31/44 , A61P3/04
CPC分类号： C07D213/62 , C07D401/12 , C07D405/12 , C07D409/12
摘要： Compounds of formula (I): or pharmaceutically acceptable salts thereof, are opioid receptor modulators, e.g. mu- opioid receptor antagonists, neutral antagonists or inverse agonists, and are useful for the treatment of metabolic disorders including obesity.
摘要翻译：式（I）化合物或其药学上可接受的盐是阿片样物质受体调节剂，例如， μ-阿片样物质受体拮抗剂，中性拮抗剂或反向激动剂，并且可用于治疗包括肥胖症在内的代谢紊乱。

9. 发明申请

WO2012066077A1 1,4 DI SUBSTITUTED PYRROLIDINE - 3 - YL -AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS 审中-公开
标题翻译： 1,4 DI替代吡咯烷-3-谷氨酸衍生物及其用于治疗代谢性疾病的用途
公开(公告)号：WO2012066077A1
公开(公告)日：2012-05-24
申请号：PCT/EP2011/070346
申请日：2011-11-17
申请人： PROSIDION LIMITED , BARBA, Oscar , BERTRAM, Lisa, Sarah , CARSWELL, Emma Louise , DAVIS, Susan, Helen , FRY, Peter, Timothy , GLEAVE, Robert James , JEEVARATNAM, Revathy, Perpetua , JOHNSTONE, Craig , KEILY, John , PROCTER, Martin, James , SCHOFIELD, Karen, Lesley , STEWART, Alan, John, William , SWAIN, Simon, Andrew
发明人： BARBA, Oscar , BERTRAM, Lisa, Sarah , CARSWELL, Emma Louise , DAVIS, Susan, Helen , FRY, Peter, Timothy , GLEAVE, Robert James , JEEVARATNAM, Revathy, Perpetua , JOHNSTONE, Craig , KEILY, John , PROCTER, Martin, James , SCHOFIELD, Karen, Lesley , STEWART, Alan, John, William , SWAIN, Simon, Andrew
IPC分类号： C07D413/14 , C07D401/14 , A61K31/506 , A61P3/10
CPC分类号： C07D413/14 , C07D401/14
摘要： Therapeutic compounds are disclosed having the general formula (1) that are useful for the treatment of metabolic disorders, including type II diabetes.The compounds have activity as agonists of GPR1 19. Compounds having the stereochemistry of formula (la) may also demonstrate DPP-IV inhibitory activity.
摘要翻译：公开了具有通式（1）的治疗化合物，其可用于治疗代谢紊乱，包括II型糖尿病。该化合物具有作为GPR119激动剂的活性。具有式（Ia）立体化学的化合物还可以显示DPP- IV抑制活性。

10. 发明申请

WO2018039559A3 MATERIALS HANDLING VEHICLE OBSTACLE SCANNING TOOLS 审中-公开
公开(公告)号：WO2018039559A3
公开(公告)日：2018-03-01
申请号：PCT/US2017/048612
申请日：2017-08-25
申请人： CROWN EQUIPMENT CORPORATION , MAI, Yuan , STEWART, Alan
发明人： MAI, Yuan , STEWART, Alan
IPC分类号： G05D1/02 , B66F9/06
摘要： A materials handling vehicle comprises an obstacle scanning tool and steering mechanism, materials handling hardware, vehicle drive mechanism, and user interface that facilitate movement of the materials handling vehicle and materials handled along a travel path. The tool establishes a scan field, a filter field, and a performance field, and is configured to indicate the presence of obstacles in the filter field and the performance field. The tool executes logic to establish the performance field in response to an input performance level, scan for obstacles in the filter field and the performance field, execute obstacle avoidance for obstacles detected in the filter field, and execute a performance level reduction inquiry for obstacles detected in the performance field wherein outcomes of the inquiry comprise reduction of the performance level when a performance level reduction is available and execution of obstacle avoidance when a performance level reduction is not available.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式